Biotech Co., Ex-Exec And Investor To Pay $5.2M In SEC Suit
By Sydney Price · February 28, 2024, 9:49 PM EST
A New York federal judge entered final judgments against medical device company RenovaCare, its controlling shareholder, and its former chief operating officer to settle a U.S. Securities and Exchange Commission suit...
To view the full article, register now.